Clinicians and researchers weigh in on the advent of precision medicine for the treatment of SLE.
New available research suggests that female physicians may not be coding for as many billable services as their male counterparts, which could explain part of the gender reimbursement gap.
Pharmacists will likely play a pivotal role in the integration of biologic biosimilars for the treatment of rheumatic disease into clinical practice once they are made available in the market.
Multidisciplinary experts provide 12 recommendations for the planning and management of pregnancy in systemic lupus erythematosus and/or antiphospholipid syndrome.
Rheumatology Advisor speaks with Erin Michos, MD, cardiologist at Johns Hopkins School of Medicine, and Eric Matteson, MD, rheumatologist at Mayo Clinic, about refining cardiovascular risk assessment in patients with rheumatoid arthritis.
The recent US Food and Drug Administration (FDA) approval of adalimumab (Humira®, AbbVie) for the treatment of noninfectious intermediate, posterior, and pan-uveitis is the first step beyond traditional corticosteroid therapy and toward use of targeted biologics for this rare ocular emergency.
Wrongful disclosure of HIPAA-protected health information can lead to patient lawsuits.
A historical analysis suggests that sugar control policies inconsistently cite coronary heart disease as a health risk.
One clinician reflects on the financial incentives provided by the Chronic Care Management (CCM) program of CMS.
Certain parts of the legislation related to HIPAA are optional and recommended, while others are mandatory
Including the 18 patients identifiers that must be removed from charts before sharing with HIPAA-covered entities.
Evaluating the types of grants young investigators are applying for could provide a better sense of how to maintain them, and to attract more back to NIH-funded research.
The National Institute for Occupational Safety and Health defines workplace violence as "violent acts, including physical assaults and threats of assault, directed toward persons at work or on duty."
Case Studies and Clinical Highlights
A female patient with systemic lupus erythematosus presents to the emergency department with an 8 week history of dyspnea, dysphonia, and non-productive cough.
AA amyloidosis is a rare but significant complication of ankylosing spondylitis (AS) and may lead to proteinuria and renal dysfunction.
Since certain syndromes are associated with good prognosis in a majority of patients with systemic lupus erythematosus, prompt diagnosis and initiation of early goal-directed treatment is crucial.
Rheumatology Advisor Articles
- Applying Precision Medicine to Systemic Lupus Erythematosus
- Updated Postmenopausal Osteoporosis Management Guidelines
- Comparative Risk of Cervical Dysplasia With bDMARDs vs csDMARDs in RA
- Efficacy of IL-6 Inhibition in csDMARD-Inadequate Responders With PsA
- Caution Expressed By Pain Specialists Over New CDC Opioid Guidelines
- Anti-drug Antibody Monitoring of TNF-α Blockers in RA
- Decreasing Morbidity Associated With Scleroderma By Addressing Pain Management
- Serum Amyloid A: An Emerging Biomarker in Early RA?
- IFI44L Promotor Methylation as a Specific Diagnostic Marker of SLE
- FRAX May Overestimate Fracture Risk in RA Patients